Skip to main content

Rome Zachary

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Rome Zachary as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PXMD Kuvatris Therapeutics, Inc.

Director8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2024 (view filing)7:55 PM ETJan 292 daysRome ZacharyDirectorSSale−811$0.48−$389.28−5.1%15.1K after
Nov 29, 2023 (view filing)Nov 272 daysRome ZacharyDirectorSSale−359$1.03−$369.77−2.2%16.0K after10b5-1
Oct 30, 2023 (view filing)4:13 PM ETOct 273 daysRome ZacharyDirectorSSale−16.3K$0.1848−$3.01K−5.6%277.4K after10b5-1
Aug 30, 2023 (view filing)4:09 PM ETAug 28-302 daysRome ZacharyDirectorSSale−25.6K$0.4827−$12.4K−8.0%293.7K after3 lots10b5-1
Aug 23, 2023 (view filing)Aug 21-222 daysRome ZacharyDirectorSSale−50.0K$0.556−$27.8K−13.5%319.3K after2 lots10b5-1
Mar 9, 2023 (view filing)Mar 8-91 dayRome ZacharyChief Operating OfficerSSale−33.4K$1.47−$49.0K−10.4%288.5K after2 lots
Mar 7, 2023 (view filing)Mar 6-71 dayRome ZacharyChief Operating OfficerSSale−37.0K$1.60−$59.2K−10.3%321.9K after2 lots
Mar 3, 2023 (view filing)Mar 2-31 dayRome ZacharyChief Operating OfficerSSale−26.2K$1.91−$50.1K−6.8%358.8K after2 lots